Educational Program Information

Completion Time: The estimated time to completion for this activity is two hours.

Target Audience: This CME/CPME/ACPE/CE activity is intended for physicians, podiatrists, pharmacists, and nurses who treat spinal-cord injured, chronic obstructive pulmonary disease (COPD), and long-term acute care (LTAC) patients, patients with pressure, acute, or chronic wounds, or patients who otherwise experience rapid weight loss.

At the conclusion of this activity, the participant should be able to:
1. Discuss current therapies for the prevention of involuntary weight loss
2. Describe the nutrition prescription in acute and chronic wound care
3. Be familiar with the use of adjunctive nutrition support for involuntary weight loss in LTAC and COPD patients and patients with wounds
4. Discuss the role of anabolic agents in wound care
5. Define significant weight loss and what type of weight is lost during metabolic stress
6. Describe how metabolic stress affects the amino acids, glutamine, and arginine resulting in loss of lean body mass
7. Describe the rationale for monitoring both serum albumin and prealbumin in the prevention and treatment of pressure ulcers
8. Define protein, calorie, fluid, and micronutrient needs for wound healing
9. Define the syndromes associated with delayed wound healing
10. Understand the pathophysiology of each syndrome
11. Identify patient populations at risk
12. Recognize medical/metabolic conditions associated with catabolic state
13. Discuss appropriate methods of assessment
14. Determine methods of intervention, including use of anabolic medication
15. Access further educational and clinical resources about this topic.

Disclosure: All faculty participating in Continuing Medical Education programs sponsored by HMP Communications are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation. Jennifer James, Evelyn Phillips, Paul Walaszek, Jeffrey Stone, and Bruce Friedman have disclosed that they are members of the speakers bureau for BTG Pharmaceuticals Inc.

Commercial Support Disclosure: This activity is financially supported through an unrestricted educational grant by BTG Pharmaceuticals Inc.

Accreditation (Physicians, Podiatrists, Pharmacists, Nurses): HMP Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. HMP Communications, LLC is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine. HMP Communications, LLC is accredited by the American Council on Pharmaceutical Education as a provider of continuing pharmaceutical education. HMP Communciations, LLC is approved by the California Board of Registered Nursing, Provider #13255.

Designation: HMP Communications designates this continuing medical education activity for 2 credit hours in Category 1 of the Physician’s Recognition Award of the American Medical Association. Each physician should claim only those hours he or she spent in the educational activity. HMP Communications designates this continuing medical activity for .2 CEUs available to participating podiatrists. HMP Communications designates this continuing education activity for 2 contact hours (0.20 CEUs) of the American Council on Pharmaceutcial Education (Universal Program Number 276-000-02-006-H04). A statement of credit will be issued only upon receipt of completed activity self test.